IBDEI0IL ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8112,1,4,0)
 ;;=4^L89.95
 ;;^UTILITY(U,$J,358.3,8112,2)
 ;;=^5133660
 ;;^UTILITY(U,$J,358.3,8113,0)
 ;;=L89.92^^65^519^29
 ;;^UTILITY(U,$J,358.3,8113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8113,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 2
 ;;^UTILITY(U,$J,358.3,8113,1,4,0)
 ;;=4^L89.92
 ;;^UTILITY(U,$J,358.3,8113,2)
 ;;=^5133667
 ;;^UTILITY(U,$J,358.3,8114,0)
 ;;=L89.93^^65^519^30
 ;;^UTILITY(U,$J,358.3,8114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8114,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 3
 ;;^UTILITY(U,$J,358.3,8114,1,4,0)
 ;;=4^L89.93
 ;;^UTILITY(U,$J,358.3,8114,2)
 ;;=^5133668
 ;;^UTILITY(U,$J,358.3,8115,0)
 ;;=L89.94^^65^519^31
 ;;^UTILITY(U,$J,358.3,8115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8115,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 4
 ;;^UTILITY(U,$J,358.3,8115,1,4,0)
 ;;=4^L89.94
 ;;^UTILITY(U,$J,358.3,8115,2)
 ;;=^5133669
 ;;^UTILITY(U,$J,358.3,8116,0)
 ;;=L89.90^^65^519^32
 ;;^UTILITY(U,$J,358.3,8116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8116,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage Unspec
 ;;^UTILITY(U,$J,358.3,8116,1,4,0)
 ;;=4^L89.90
 ;;^UTILITY(U,$J,358.3,8116,2)
 ;;=^5133666
 ;;^UTILITY(U,$J,358.3,8117,0)
 ;;=L89.91^^65^519^28
 ;;^UTILITY(U,$J,358.3,8117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8117,1,3,0)
 ;;=3^Pressure Ulcer Unspec Site,Stage 1
 ;;^UTILITY(U,$J,358.3,8117,1,4,0)
 ;;=4^L89.91
 ;;^UTILITY(U,$J,358.3,8117,2)
 ;;=^5133664
 ;;^UTILITY(U,$J,358.3,8118,0)
 ;;=L76.21^^65^519^25
 ;;^UTILITY(U,$J,358.3,8118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8118,1,3,0)
 ;;=3^Postprocedure Hemorrhage of Skin/SQ Tissue After Derm Procedure
 ;;^UTILITY(U,$J,358.3,8118,1,4,0)
 ;;=4^L76.21
 ;;^UTILITY(U,$J,358.3,8118,2)
 ;;=^5009306
 ;;^UTILITY(U,$J,358.3,8119,0)
 ;;=L76.22^^65^519^26
 ;;^UTILITY(U,$J,358.3,8119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8119,1,3,0)
 ;;=3^Postprocedure Hemorrhage of Skin/SQ Tissue After Oth Procedure
 ;;^UTILITY(U,$J,358.3,8119,1,4,0)
 ;;=4^L76.22
 ;;^UTILITY(U,$J,358.3,8119,2)
 ;;=^5009307
 ;;^UTILITY(U,$J,358.3,8120,0)
 ;;=L41.9^^65^519^3
 ;;^UTILITY(U,$J,358.3,8120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8120,1,3,0)
 ;;=3^Parapsoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,8120,1,4,0)
 ;;=4^L41.9
 ;;^UTILITY(U,$J,358.3,8120,2)
 ;;=^5009177
 ;;^UTILITY(U,$J,358.3,8121,0)
 ;;=L70.5^^65^519^14
 ;;^UTILITY(U,$J,358.3,8121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8121,1,3,0)
 ;;=3^Picker's Acne
 ;;^UTILITY(U,$J,358.3,8121,1,4,0)
 ;;=4^L70.5
 ;;^UTILITY(U,$J,358.3,8121,2)
 ;;=^5009272
 ;;^UTILITY(U,$J,358.3,8122,0)
 ;;=L81.9^^65^519^15
 ;;^UTILITY(U,$J,358.3,8122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8122,1,3,0)
 ;;=3^Pigmentation Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,8122,1,4,0)
 ;;=4^L81.9
 ;;^UTILITY(U,$J,358.3,8122,2)
 ;;=^5009319
 ;;^UTILITY(U,$J,358.3,8123,0)
 ;;=L66.3^^65^519^7
 ;;^UTILITY(U,$J,358.3,8123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8123,1,3,0)
 ;;=3^Perifolliculitis Capitis Abscedens
 ;;^UTILITY(U,$J,358.3,8123,1,4,0)
 ;;=4^L66.3
 ;;^UTILITY(U,$J,358.3,8123,2)
 ;;=^5009255
 ;;^UTILITY(U,$J,358.3,8124,0)
 ;;=R23.3^^65^519^13
 ;;^UTILITY(U,$J,358.3,8124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8124,1,3,0)
 ;;=3^Petechiae
 ;;^UTILITY(U,$J,358.3,8124,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,8124,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,8125,0)
 ;;=D69.3^^65^519^46
